China Health Group Ltd

As of September 30, 2025, China Health Group Ltd carries a market capitalization of 291.61M, placing it among publicly traded companies globally. Its enterprise value stands at 241.97M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2025, China Health Group Ltd has 613.91M shares outstanding.

These figures are as of September 30, 2025.

As of September 30, 2025, China Health Group Ltd maintains a current ratio of 0.80, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended September 30, 2025.

As of the close on October 15, 2026, China Health Group Ltd's stock has declined approximately 40.45% over the past 52 weeks. The 50-day moving average sits at 0.38, while the 200-day moving average is 0.55.

As of September 30, 2025, China Health Group Ltd holds 63.02M in cash and equivalents against 6.05M in total debt, resulting in a net debt position of -57.54M. Total book value stands at -17.83M, with working capital of -42.45M providing operational flexibility.

China Health Group Ltd's most recent stock split took place on August 25, 2025 with a 760:949 split ratio.